Pulmonary Arterial Hypertension Secondary to Drugs and Toxins-Reference-Cited by-同舟云学术

Pulmonary Arterial Hypertension Secondary to Drugs and Toxins

Published:2021-03 Issue:1 Volume:42 Page:19-38
ISSN:0272-5231
Container-title:Clinics in Chest Medicine
language:en
Short-container-title:Clinics in Chest Medicine

Author:

Ramirez Ramon L.,Pienkos Shaun M.,de Jesus Perez Vinicio,Zamanian Roham T.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine

Reference140 articles.

1. Ueber sklerose der lungen arterie;Romberg;Dtsch Arch Klin Med,1891

2. Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?;Gurtner;Bull Eur Physiopathol Respir,1979

3. Drug-induced pulmonary hypertension?;Follath;Br Med J,1971

4. Haemodynamic definitions and updated clinical classification of pulmonary hypertension;Simonneau;Eur Respir J,2019

5. Aminorex and pulmonary hypertension. A Review;Gurtner;Cor Vasa,1985

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical–radiological–pathological correlation in pulmonary arterial hypertension;European Respiratory Review;2023-12-20

2. Fatty Oil of Descurainia Sophia Nanoparticles Improve Monocrotaline-Induced Pulmonary Hypertension in Rats Through PLC/IP3R/Ca2+ Signaling Pathway;International Journal of Nanomedicine;2023-12

3. Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis;British Journal of Clinical Pharmacology;2022-07-10

4. Insights on the Gut-Mesentery-Lung Axis in Pulmonary Arterial Hypertension: A Poorly Investigated Crossroad;Arteriosclerosis, Thrombosis, and Vascular Biology;2022-05

5. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies;American Journal of Physiology-Heart and Circulatory Physiology;2022-05-01